EMBERA NEUROTHERAPEUTICS
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.
EMBERA NEUROTHERAPEUTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2005-01-01
Address:
Sudbury, Massachusetts, United States
Country:
United States
Website Url:
http://www.emberaneuro.com
Total Employee:
11+
Status:
Active
Contact:
+1 (318) 213-0198
Total Funding:
28.41 M USD
Technology used in webpage:
IPv6 Google Maps Google Maps API Cloudflare Hosting Cloudflare DNS Intermedia
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Catalyst
Innovation Catalyst investment in Series A - Embera NeuroTherapeutics
Rose Research Center (RRC) in North Carolina
Rose Research Center (RRC) in North Carolina investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Series B - Embera NeuroTherapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
HRA Pharma
HRA Pharma investment in Series A - Embera NeuroTherapeutics
Official Site Inspections
http://www.emberaneuro.com Semrush global rank: 5.85 M Semrush visits lastest month: 1.42 K
- Host name: 104.21.25.122
- IP address: 104.21.25.122
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
